Table 2.
Overview of assessment tiers, outlining the composition of each in relation to methodologies incorporated
| Assessment tier | Approach overview | Methodologies incorporated | Category assignment |
|---|---|---|---|
| 0 | Cramer classification | Cramer scheme (with extensions) | Classification-category probability distribution (Table 5) |
| 1 | In silico | EPA TEST LD50 | Bayesian model |
| Random forest LD50 | |||
| Structural alerts | |||
| 2 | In vitro | In vitro cytotoxicity (cell viability assay) | Bayesian model |
| 3 (hypothetical) | In vivo | OECD Test Guideline 425: Acute oral toxicity | Experimental outcome |